UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014

BMC cancer, 2018-11, Vol.18 (1), p.1075-1075, Article 1075

2018

Volltextzugriff (PDF)

Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia

Haematologica (Roma), 2020-03, Vol.105 (3), p.708-720

2020

Volltextzugriff (PDF)

Established Human Cell Lines as Models to Study Anti-leukemic Effects of Flavonoids

Current genomics, 2017-02, Vol.18 (1), p.3-26

2017

Volltextzugriff (PDF)

Sulfotransferase 1A1 as a Biomarker for Susceptibility to Carcinogenesis: From Molecular Genetics to the Role of Dietary Flavonoids

Current drug metabolism, 2016-01, Vol.17 (6), p.528-541

2016

Volltextzugriff (PDF)

Role of flavonoids in future anticancer therapy by eliminating the cancer stem cells

Current stem cell research & therapy, 2015-01, Vol.10 (3), p.271-282

2015

Volltextzugriff (PDF)

Chemomodulating Effects of Flavonoids in Human Leukemia Cells

Anti-cancer agents in medicinal chemistry, 2015-01, Vol.15 (9), p.1112-1126

2015

Volltextzugriff (PDF)

Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients

Supportive care in cancer, 2013-01, Vol.21 (1), p.343-355

2013

Volltextzugriff (PDF)

Multi-Target Cytotoxic Actions of Flavonoids in Blood Cancer Cells

Asian Pacific journal of cancer prevention : APJCP, 2015-07, Vol.16 (12), p.4843-4847

2015

Volltextzugriff (PDF)

Potentiation of luteolin cytotoxicity by flavonols fisetin and quercetin in human chronic lymphocytic leukemia cell lines

Food & function, 2016-09, Vol.7 (9), p.3815-3824

2016

Volltextzugriff (PDF)

Hematopoietic stem cell transplantation (HSCT) as an example of personalized approach in the management of individual disease

The EPMA journal, 2014-02, Vol.5 (Suppl 1), p.1-A62, Article A62

Everaus, Hele

2014

Volltextzugriff (PDF)

Closer to personalized approach through accepting the gender differences in medicine

The EPMA journal, 2014-02, Vol.5 (Suppl 1), p.1-A148, Article A148

Everaus, Hele

2014

Volltextzugriff (PDF)

Multi-Target Cytotoxic Actions of Flavonoids in Blood Cancer Cells

Asian Pacific journal of cancer prevention : APJCP, 2015, Vol.16 (12), p.4843-4847

2015

Volltextzugriff (PDF)

Involvement of P2Y receptors in the differentiation of haematopoietic cells

Journal of leukocyte biology, 2003-04, Vol.73 (4), p.442-447

2003

Volltextzugriff (PDF)

Increasing incidence and survival of corpus uteri cancer in Estonia over the past two decades

Cancer epidemiology, 2019-10, Vol.62, p.101566-101566, Article 101566

2019

Volltextzugriff (PDF)

Polymorphisms in COMT and SULT1A1 Genes and Chronic Lymphocytic Leukemia Risk in Estonia

Eurasian journal of medicine and oncology, 2019

Sak, Katrin

2019

Volltextzugriff (PDF)

Safety and efficacy of durvalumab with R-CHOP or R2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial

International journal of hematology, 2022-02, Vol.115 (2), p.222-232

2022

Volltextzugriff (PDF)

Changes in the natural history of renal cancer: comparison of Estonian data from the periods 1986-1988 and 1996-1998

International urology and nephrology, 2007, Vol.39 (1), p.35-41

2007

Volltextzugriff (PDF)

Phase II study of durvalumab (anti-PD-L1 antibody) in combination with R-CHOP or lenalidomide plus R-CHOP in previously untreated, high-risk diffuse large B-cell lymphoma

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS7573-TPS7573

2017

Volltextzugriff (PDF)

Time Trends in Ovarian Cancer Survival in Estonia by Age and Stage

International journal of gynecological cancer, 2017-01, Vol.27 (1), p.44-49

2017

Volltextzugriff (PDF)

Safety and efficacy of PD-L1 inhibitor durvalumab with R-CHOP or R 2 -CHOP in subjects with previously untreated, high-risk DLBCL

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.7520-7520

2019

Volltextzugriff (PDF)

XRCC5 Plays an Important Role in Homologous Recombination, Genome Stability and Survival of Myeloma Cells

Blood, 2015-12, Vol.126 (23), p.1218-1218

2015

Volltextzugriff (PDF)

Acute de novo Leukemia in Estonia and Western Sweden 1982-2006: Positive Trend in the Survival of Acute Leukemia over 25 Years

Acta haematologica, 2016-01, Vol.136 (3), p.167-173

2016

Volltextzugriff (PDF)

Safety and efficacy of durvalumab with R-CHOP or R 2 -CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial

International journal of hematology, 2022-02, Vol.115 (2), p.222

2022

Volltextzugriff (PDF)

Nongenomic effects of 17β-estradiol—diversity of membrane binding sites

Journal of Steroid Biochemistry and Molecular Biology, 2004-04, Vol.88 (4), p.323-335

2004

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(47)
Buchkapitel
(2)

Sprache

Englisch
(48)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014

Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia

Established Human Cell Lines as Models to Study Anti-leukemic Effects of Flavonoids

Sulfotransferase 1A1 as a Biomarker for Susceptibility to Carcinogenesis: From Molecular Genetics to the Role of Dietary Flavonoids

The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia

Role of flavonoids in future anticancer therapy by eliminating the cancer stem cells

Chemomodulating Effects of Flavonoids in Human Leukemia Cells

Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients

Multi-Target Cytotoxic Actions of Flavonoids in Blood Cancer Cells

Potentiation of luteolin cytotoxicity by flavonols fisetin and quercetin in human chronic lymphocytic leukemia cell lines

Hematopoietic stem cell transplantation (HSCT) as an example of personalized approach in the management of individual disease

Closer to personalized approach through accepting the gender differences in medicine

Multi-Target Cytotoxic Actions of Flavonoids in Blood Cancer Cells

Involvement of P2Y receptors in the differentiation of haematopoietic cells

Increasing incidence and survival of corpus uteri cancer in Estonia over the past two decades

Polymorphisms in COMT and SULT1A1 Genes and Chronic Lymphocytic Leukemia Risk in Estonia

Safety and efficacy of durvalumab with R-CHOP or R2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial

Changes in the natural history of renal cancer: comparison of Estonian data from the periods 1986-1988 and 1996-1998

Phase II study of durvalumab (anti-PD-L1 antibody) in combination with R-CHOP or lenalidomide plus R-CHOP in previously untreated, high-risk diffuse large B-cell lymphoma

Time Trends in Ovarian Cancer Survival in Estonia by Age and Stage

Safety and efficacy of PD-L1 inhibitor durvalumab with R-CHOP or R 2 -CHOP in subjects with previously untreated, high-risk DLBCL

XRCC5 Plays an Important Role in Homologous Recombination, Genome Stability and Survival of Myeloma Cells

Acute de novo Leukemia in Estonia and Western Sweden 1982-2006: Positive Trend in the Survival of Acute Leukemia over 25 Years

Safety and efficacy of durvalumab with R-CHOP or R 2 -CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial

Nongenomic effects of 17β-estradiol—diversity of membrane binding sites

Suchergebnisse filtern